Brainstorm Cell Theraputc (BCLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,251 | 3,503 | 1,317 | 1,923 | 93 |
| Marketable Securities | 4,290 | N/A | 2,769 | N/A | N/A |
| Receivables | 1,005 | 910 | 742 | 312 | 427 |
| TOTAL | $9,578 | $4,446 | $4,874 | $2,304 | $579 |
| Non-Current Assets | |||||
| PPE Net | 313 | 258 | 247 | 314 | 419 |
| Other Non-Current Assets | 20 | 22 | 17 | 126 | 91 |
| TOTAL | $333 | $280 | $264 | $440 | $510 |
| Total Assets | $9,911 | $4,726 | $5,138 | $2,744 | $1,089 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 137 |
| Accounts payable and accrued liabilities | 1,766 | 455 | 551 | 385 | 838 |
| Accrued Expenses | 1,347 | 877 | 605 | 750 | 448 |
| TOTAL | $3,113 | $1,332 | $1,156 | $1,135 | $1,423 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 123 | 655 | 0 | 121 | 125 |
| TOTAL | $123 | $655 | $N/A | $121 | $125 |
| Total Liabilities | $3,236 | $1,987 | $1,156 | $1,256 | $1,548 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,227 | 784 | 673 | 563 | 526 |
| Common Shares | 11 | 8 | 7 | 6 | 5 |
| Retained earnings | -61,653 | -52,407 | -47,508 | -44,078 | -40,160 |
| TOTAL | $6,675 | $2,739 | $3,982 | $1,488 | $-459 |
| Total Liabilities And Equity | $9,911 | $4,726 | $5,138 | $2,744 | $1,089 |